Article
MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 2013
van den Bent Martin J, Erdem-Eraslan Lale, Idbaih Ahmed, de Rooi Johan, Eilers Paul H C, Spliet Wim G M, den Dunnen Wilfred F A, Tijssen Cees, Wesseling Pieter, Sillevis Smitt Peter A E, Kros Johan M, Gorlia Thierry, French Pim J
Abstract excerpt
PURPOSE: The long-term follow-up results from the EORTC-26951 trial showed that the addition of procarbazine, CCNU, and vincristine (PCV) after radiotherapy increases survival in anaplastic oligodendrogliomas/oligoastrocytomas (AOD/AOA). However, some patients appeared to benefit more from PCV tr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
